Log in to save to my catalogue

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prosp...

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prosp...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_12688_f1000research_53327_1

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prospective study. [version 1; peer review: 1 approved with reservations, 1 not approved]

About this item

Full title

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prospective study. [version 1; peer review: 1 approved with reservations, 1 not approved]

Journal title

F1000 research, 2021, Vol.10, p.534

Language

English

Formats

More information

Scope and Contents

Contents

Background: Colitis is a frequent immune-related toxicity, without any biomarker that may predict its onset. It is endoscopically similar to intestinal inflammatory diseases, where fecal calprotectin (FC) is used as a biomarker to early-detect a relapse. We found contradictory evidence about FC and immunotherapy and no prospective study was already...

Alternative Titles

Full title

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prospective study. [version 1; peer review: 1 approved with reservations, 1 not approved]

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_12688_f1000research_53327_1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_12688_f1000research_53327_1

Other Identifiers

ISSN

2046-1402

E-ISSN

2046-1402

DOI

10.12688/f1000research.53327.1

How to access this item